Table 2.
Treatment adherence and adverse events in patients treated with nirmatrelvir/ritonavir (Group A, n = 200).
| Treated Patients (n = 200) n, (%) |
p Value | |
|---|---|---|
|
Treatment Adherence Partial (missing pills) Total (no missing pills) |
5 (2.5) 195 (97.5) |
0.421 - - |
| Adverse Events | ||
| Any adverse reaction | 23 (11.5) | 0.257 |
| Adverse reaction above Grade 3 | 0 | - |
| Treatment for adverse reaction | 2 (1) | - |
| Discontinuation of treatment | 0 | - |
| Need for extended hospitalization | 0 | - |
| Additional clinical visit | 0 | - |
|
5 (2.5) | - |
|
9 (4.5) | - |
|
5 (2.5) | - |
|
7 (3.5) | - |